Calvin R Sumner

Summary

Publications

  1. ncbi Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
    Calvin R Sumner
    Lilly USA, LLC, IN, USA
    Child Adolesc Psychiatry Ment Health 3:40. 2009
  2. ncbi Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
    Calvin R Sumner
    BioBehavioral Diagnostics Company, Plymouth Meeting, PA, 239 Littleton Rd, Ste 6A, Westford, MA 01886, USA
    Postgrad Med 122:52-61. 2010

Collaborators

Detail Information

Publications2

  1. ncbi Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
    Calvin R Sumner
    Lilly USA, LLC, IN, USA
    Child Adolesc Psychiatry Ment Health 3:40. 2009
    ..TRIAL REGISTRATION: CLINICAL TRIAL REGISTRY: ClinicalTrials.gov: NCT00191048...
  2. ncbi Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
    Calvin R Sumner
    BioBehavioral Diagnostics Company, Plymouth Meeting, PA, 239 Littleton Rd, Ste 6A, Westford, MA 01886, USA
    Postgrad Med 122:52-61. 2010
    ....